Cristin Rothfuss Sarepta Therapeutics, Inc. (SRPT) insider trading activity
Cristin Rothfuss is EVP, General Counsel of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 11,847 shares of SRPT, which is worth approximately $1.18 Million. The most recent transaction as insider was on Mar 07, 2025, when has been sold 1,478 shares (Common Stock) at a price of $103.7 per share, resulting in proceeds of $153,268. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
11.8K
14.26%
3M change
n/a
12M change
Total Value Held
$1.18 Million
Cristin Rothfuss Transaction History
CR
Cristin Rothfuss
EVP, General Counsel
Cambridge, MA